Enteritis and gastritis in young asymptomatic Pakistani men.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 5910503)

Published in Am J Dig Dis on April 01, 1966

Authors

P K Russell, M A Aziz, N Ahmad, T H Kent, E J Gangarosa

Articles by these authors

(truncated to the top 100)

Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23

Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06

Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40

The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J Virol (1988) 5.94

A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78

Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28

Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77

Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75

A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71

Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45

Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis (1970) 3.41

Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25

Flaviviridae. Intervirology (1985) 3.06

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis (1998) 3.05

Impact in the United States of the Shiga dysentery pandemic of Central America and Mexico: a review of surveillance data through 1972. J Infect Dis (1974) 2.91

Scombroid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA (1974) 2.84

Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67

The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64

Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri. J Bacteriol (1966) 2.60

Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57

Bunyaviridae. Intervirology (1980) 2.53

Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr (2000) 2.52

Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46

Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45

International outbreak of Salmonella Eastbourne infection traced to contaminated chocolate. Lancet (1975) 2.32

Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32

Shigella surveillance in the United States, 1975. J Infect Dis (1977) 2.31

Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29

Green tea and skin. Arch Dermatol (2000) 2.29

Detection of Vibrio cholerae biotype El Tor by purging. Bull World Health Organ (1966) 2.27

Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol (1966) 2.23

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19

Turtle-associated salmonellosis. I. An estimation of the magnitude of the problem in the United States, 1970-1971. Am J Epidemiol (1972) 2.15

Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol (1969) 2.13

Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97

Togaviridae. Intervirology (1985) 1.96

Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95

Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94

During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell Microbiol (2007) 1.94

Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94

Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J (1996) 1.93

Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88

Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85

Food poisoning due to Vibrio parahaemolyticus. Annu Rev Med (1974) 1.85

Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ (1971) 1.84

Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83

Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation. Lancet (1967) 1.83

Comparison of media for direct isolation and transport of Shigellae from Fecal specimens. Appl Microbiol (1970) 1.82

Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80

Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79

Epidemiology of an international outbreak of Salmonella agona. Lancet (1973) 1.76

Holding media for the transport of Vibrio cholerae from field to laboratory. Am J Trop Med Hyg (1971) 1.75

Epidemiology of cholera in Italy in 1973. Lancet (1974) 1.75

An epidemic-associated episome? J Infect Dis (1972) 1.72

Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72

Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71

Salmonella gastroenteritis in rhesus monkeys. Arch Pathol (1966) 1.70

Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69

Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69

Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69

The timing of calcium measurements in helping to predict temporary and permanent hypocalcaemia in patients having completion and total thyroidectomies. Ann R Coll Surg Engl (2009) 1.69

An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68

Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67

Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus. J Virol (1988) 1.67

Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66

The biosynthesis of some androst-16-enes from C21 and C19 steroids in boar testicular and adrenal tissue. Biochem J (1968) 1.64

Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64

An assessment of patient-related economic costs in an outbreak of salmonellosis. N Engl J Med (1978) 1.63

The proteins of Japanese encephalitis virus. Virology (1971) 1.63

Clinical features of types A and B food-borne botulism. Ann Intern Med (1981) 1.62

Cholera in Portugal, 1974.I. Modes of transmission. Am J Epidemiol (1977) 1.62

An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61

Epidemiologic assessment of the relevance of the so-called enteropathogenic serogroups of Escherichia coli in diarrhea. N Engl J Med (1977) 1.59

Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58

Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58

Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol (2000) 1.55

Laboratory methods in cholera: isolation of Vibrio cholerae (el tor and classical) on TCBS medium in minimally equipped laboratories. Trans R Soc Trop Med Hyg (1968) 1.52

Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51

Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol (2010) 1.50

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol (2001) 1.48

Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47

'I can't do any serious exercise': barriers to physical activity amongst people of Pakistani and Indian origin with Type 2 diabetes. Health Educ Res (2005) 1.46

Institutional salmonellosis. J Infect Dis (1973) 1.46

MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44

Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am J Med (1985) 1.44

Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44

Green tea in chemoprevention of cancer. Toxicol Sci (1999) 1.41

Pharmacokinetic evaluation of enrofloxacin in chickens. Br Poult Sci (1997) 1.40

Shigellosis in custodial institutions. Am J Epidemiol (1970) 1.40

Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg (2007) 1.39

Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969. J Infect Dis (1970) 1.39

Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J Infect Dis (1972) 1.39

Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39

Evaluation of thiosulfate-citrate-bile salts-sucrose agar, a selective medium for the isolation of Vibrio cholerae and other pathogenic vibrios. J Infect Dis (1974) 1.39